These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16817757)

  • 1. Cellular immunity and lung injury in respiratory virus infection.
    Bruder D; Srikiatkhachorn A; Enelow RI
    Viral Immunol; 2006; 19(2):147-55. PubMed ID: 16817757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular senescence: friend or foe to respiratory viral infections?
    Kelley WJ; Zemans RL; Goldstein DR
    Eur Respir J; 2020 Dec; 56(6):. PubMed ID: 33033152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of microRNAs in respiratory viral infection: friend or foe?
    Tahamtan A; Inchley CS; Marzban M; Tavakoli-Yaraki M; Teymoori-Rad M; Nakstad B; Salimi V
    Rev Med Virol; 2016 Nov; 26(6):389-407. PubMed ID: 27373545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Building a human lung from pluripotent stem cells to model respiratory viral infections.
    Turner DL; Amoozadeh S; Baric H; Stanley E; Werder RB
    Respir Res; 2024 Jul; 25(1):277. PubMed ID: 39010108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral-bacterial synergistic interaction in respiratory disease.
    Babiuk LA; Lawman MJ; Ohmann HB
    Adv Virus Res; 1988; 35():219-49. PubMed ID: 3148270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza virus-related critical illness: pathophysiology and epidemiology.
    Kalil AC; Thomas PG
    Crit Care; 2019 Jul; 23(1):258. PubMed ID: 31324202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The host immune response in respiratory virus infection: balancing virus clearance and immunopathology.
    Newton AH; Cardani A; Braciale TJ
    Semin Immunopathol; 2016 Jul; 38(4):471-82. PubMed ID: 26965109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza lung injury: mechanisms and therapeutic opportunities.
    Gregory DJ; Kobzik L
    Am J Physiol Lung Cell Mol Physiol; 2015 Nov; 309(10):L1041-6. PubMed ID: 26408556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cytokine storm of severe influenza and development of immunomodulatory therapy.
    Liu Q; Zhou YH; Yang ZQ
    Cell Mol Immunol; 2016 Jan; 13(1):3-10. PubMed ID: 26189369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia.
    de Jong MD; Simmons CP; Thanh TT; Hien VM; Smith GJ; Chau TN; Hoang DM; Chau NV; Khanh TH; Dong VC; Qui PT; Cam BV; Ha do Q; Guan Y; Peiris JS; Chinh NT; Hien TT; Farrar J
    Nat Med; 2006 Oct; 12(10):1203-7. PubMed ID: 16964257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate and adaptive immune responses in respiratory virus infection: implications for the clinic.
    Stambas J; Lu C; Tripp RA
    Expert Rev Respir Med; 2020 Nov; 14(11):1141-1147. PubMed ID: 32762572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of polyphenols against complications of COVID-19: current evidence and potential efficacy.
    Vajdi M; Karimi A; Hassanizadeh S; Farhangi MA; Bagherniya M; Askari G; Roufogalis BD; Davies NM; Sahebkar A
    Pharmacol Rep; 2024 Apr; 76(2):307-327. PubMed ID: 38498260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of Nucleocapsid-Targeting Vaccines against COVID-19.
    Rak A; Isakova-Sivak I; Rudenko L
    Vaccines (Basel); 2023 Dec; 11(12):. PubMed ID: 38140214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleoprotein as a Promising Antigen for Broadly Protective Influenza Vaccines.
    Rak A; Isakova-Sivak I; Rudenko L
    Vaccines (Basel); 2023 Nov; 11(12):. PubMed ID: 38140152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissection of key factors correlating with H5N1 avian influenza virus driven inflammatory lung injury of chicken identified by single-cell analysis.
    Dai M; Zhu S; An Z; You B; Li Z; Yao Y; Nair V; Liao M
    PLoS Pathog; 2023 Oct; 19(10):e1011685. PubMed ID: 37819993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in Mice.
    Langenmayer MC; Luelf-Averhoff AT; Marr L; Jany S; Freudenstein A; Adam-Neumair S; Tscherne A; Fux R; Rojas JJ; Blutke A; Sutter G; Volz A
    Pathogens; 2023 Jun; 12(7):. PubMed ID: 37513714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant effects of combination monophosphoryl lipid A and poly I:C on antigen-specific immune responses and protective efficacy of influenza vaccines.
    Le CTT; Ahn SY; Ho TL; Lee J; Lee DH; Hwang HS; Kang SM; Ko EJ
    Sci Rep; 2023 Jul; 13(1):12231. PubMed ID: 37507413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Truncation of NS1 Protein Enhances T Cell-Mediated Cross-Protection of a Live Attenuated Influenza Vaccine Virus Expressing Wild-Type Nucleoprotein.
    Prokopenko P; Matyushenko V; Rak A; Stepanova E; Chistyakova A; Goshina A; Kudryavtsev I; Rudenko L; Isakova-Sivak I
    Vaccines (Basel); 2023 Feb; 11(3):. PubMed ID: 36992084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cells promote granulomatous inflammation during chronic Mycobacterium tuberculosis infection in mice.
    Chen Y; Bharrhan S; Xu J; Sharma T; Wang Y; Salgame P; Zhang J; Nargan K; Steyn AJC; Maglione PJ; Chan J
    PLoS Pathog; 2023 Mar; 19(3):e1011187. PubMed ID: 36888692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide exploration of a pyroptosis-related gene module along with immune cell infiltration patterns in bronchopulmonary dysplasia.
    Chen L; Shi C; Zhou G; Yang X; Xiong Z; Ma X; Zhu L; Ma X; Mao Y; Hu Y; Wang J; Tang X; Bao Y; Ma Y; Luo F; Wu C; Jiang F
    Front Genet; 2022; 13():1074723. PubMed ID: 36685920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.